Liver function abnormalities following alemtuzumab (Campath-1H): A previously unrecognised first dose effect

D Milojkovic, Z Y Lim, C Britten, J Chappell, A Ho, R Duarte, A Pagliuca, S Devereux, G J Mufti

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	244
Number of pages	1
Journal	British Journal of Haematology
Volume	129
Publication status	Published - 2005
Event	45th Annual Scientific Meeting of the British-Society-for-Haematology - Manchester, ENGLAND Duration: 11 Apr 2005 → 13 Apr 2005

Cite this

@article{47c45b729ea64abf876ae97c278c86e5,

title = "Liver function abnormalities following alemtuzumab (Campath-1H): A previously unrecognised first dose effect",

author = "D Milojkovic and Lim, {Z Y} and C Britten and J Chappell and A Ho and R Duarte and A Pagliuca and S Devereux and Mufti, {G J}",

year = "2005",

language = "English",

volume = "129",

pages = "244",

journal = "British Journal of Haematology",

issn = "1365-2141",

publisher = "Wiley-Blackwell Publishing Ltd",

note = "45th Annual Scientific Meeting of the British-Society-for-Haematology ; Conference date: 11-04-2005 Through 13-04-2005",

}

TY - JOUR

T1 - Liver function abnormalities following alemtuzumab (Campath-1H): A previously unrecognised first dose effect

AU - Milojkovic, D

AU - Lim, Z Y

AU - Britten, C

AU - Chappell, J

AU - Ho, A

AU - Duarte, R

AU - Pagliuca, A

AU - Devereux, S

AU - Mufti, G J

PY - 2005

Y1 - 2005

M3 - Meeting abstract

SN - 1365-2141

VL - 129

SP - 244

JO - British Journal of Haematology

JF - British Journal of Haematology

T2 - 45th Annual Scientific Meeting of the British-Society-for-Haematology

Y2 - 11 April 2005 through 13 April 2005

ER -